Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

Original languageEnglish
Pages (from-to)1131-1137
Number of pages7
JournalCurrent Medical Research and Opinion
Volume21
Issue number7
DOIs
StatePublished - Jul 1 2005
Externally publishedYes

Fingerprint

Cataract
Patient Care
Anti-Inflammatory Agents
Guidelines
Drug Therapy
Pharmaceutical Preparations
Macular Edema
Therapeutics
Prodrugs
Adrenal Cortex Hormones
Inflammation
Population

Keywords

  • Cataract treatment strategy
  • Cystoid macular edema
  • Nonsteroidal antiinflammatory drugs

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. / O'Brien, Terrence.

In: Current Medical Research and Opinion, Vol. 21, No. 7, 01.07.2005, p. 1131-1137.

Research output: Contribution to journalArticle

@article{0819d51a064541afa2727c8747308138,
title = "Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care",
abstract = "This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.",
keywords = "Cataract treatment strategy, Cystoid macular edema, Nonsteroidal antiinflammatory drugs",
author = "Terrence O'Brien",
year = "2005",
month = "7",
day = "1",
doi = "10.1185/030079905X50651",
language = "English",
volume = "21",
pages = "1131--1137",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

AU - O'Brien, Terrence

PY - 2005/7/1

Y1 - 2005/7/1

N2 - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

AB - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

KW - Cataract treatment strategy

KW - Cystoid macular edema

KW - Nonsteroidal antiinflammatory drugs

UR - http://www.scopus.com/inward/record.url?scp=22744455811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22744455811&partnerID=8YFLogxK

U2 - 10.1185/030079905X50651

DO - 10.1185/030079905X50651

M3 - Article

VL - 21

SP - 1131

EP - 1137

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 7

ER -